Fertility and Sterility
Volume 93, Issue 3 , Pages 691-696 , February 2010

Cancer and fecundity issues mandate a multidisciplinary approach

  • Dominique de Ziegler, M.D.

      Affiliations

    • Université Paris Descartes, Service de Gynécologie Obstétrique II et Médecine de la Reproduction, Paris, France
    • Corresponding Author InformationReprint requests: D. de Ziegler, M.D., Service de Gynécologie Obstétrique II, Hôpital St. Vincent de Paul, 82 Bd Denfert-Rocherau, 75014 Paris, France (FAX: 33-1 58 41 1870).
    • ,
  • Isabelle Streuli, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Hospital of Morges, Morges, Switzerland
    • ,
  • Ioannis Vasilopoulos, M.D.

      Affiliations

    • Université Paris Descartes, Service de Gynécologie Obstétrique II et Médecine de la Reproduction, Paris, France
    • ,
  • Christine Decanter, M.D.

      Affiliations

    • Department of Endocrine Gynecology and Reproductive Medicine, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire (CHRU), Lille, France
    • ,
  • Pascale This, M.D.

      Affiliations

    • Institut Curie, Paris, France
    • ,
  • Charles Chapron, M.D.

      Affiliations

    • Université Paris Descartes, Service de Gynécologie Obstétrique II et Médecine de la Reproduction, Paris, France

Received 30 October 2008 ,Revised 8 December 2008 ,Accepted 11 December 2008.

References 

  1. Partridge AH, Gelber S, Peppercorn J, Ginsburg E, Sampson E, Rosenberg R, et al. Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer. 2008;8:65–69
  2. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–4183
  3. Zaman K, Ambrosetti A, Perey L, Jeanneret-Sozzi W, Delaloye JF, de Ziegler D. Breast cancer in young women: adjuvant therapy and fertility. Rev Med Suisse. 2007;112:1298–1300
  4. Levi F, La Vecchia C. Cancer epidemiology and trends in Switzerland. Bull Cancer. 2007;94:775–780
  5. Levi F, Randimbison L, Te VC, Franceschi S, La Vecchia C. Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993. Ann Oncol. 2000;11:957–963
  6. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med. 2000;342:564–571
  7. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005;83:979–987
  8. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718
  9. Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90:395–400
  10. Streuli I, Fraisse T, Chapron C, Bijaoui G, Bischof P, de Ziegler D. Clinical uses of anti-Müllerian hormone assays: pitfalls and promises. Fertil Steril. 2008 Feb 2;[Epub ahead of print]
  11. Decanter C, Pigny P, Morschauser F, Galloo , Lefebvre C, Dewailly D. Anti-mullerian hormone (AMH) levels prior to, during and after chemotherapy for lymphoma: a longitudinal study in 17 women. Fertil Steril. 2007;88:S14–S15
  12. von der Weid NX. Adult life after surviving lymphoma in childhood. Support Care Cancer. 2008;16:339–345
  13. De Bruin ML, Huisbrink J, Hauptmann M, Kuenen MA, Ouwens GM, van't Veer MB, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood. 2008;111:101–108
  14. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405–1410
  15. Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod. 2008;23:2266–2272
  16. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7:1342–1346
  17. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008;23:699–708
  18. Cooper GS, Thorp JM. FSH levels in relation to hysterectomy and to unilateral oophorectomy. Obstet Gynecol. 1999;94:969–972
  19. Cramer DW, Xu H, Harlow BL. Does “incessant” ovulation increase risk for early menopause?. Am J Obstet Gynecol. 1995;172:568–573
  20. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91:3885–3890
  21. Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab. 2007;92:2197–2200
  22. Wright VC, Chang J, Jeng G, Macaluso M. Centers for Disease Control and Prevention (CDC). Assisted reproductive technology surveillance—United States 2005. MMWR Surveill Summ. 2008;57:1–23

 D.deZ. holds stock in Ultrst, LLC. I.S. has nothing to disclose. I.V. has nothing to disclose. C.D. has nothing to disclose. P.T. has received grants from Pfizer and Novartis. C.C. has nothing to disclose.

PII: S0015-0282(08)04726-2

doi: 10.1016/j.fertnstert.2008.12.028

Fertility and Sterility
Volume 93, Issue 3 , Pages 691-696 , February 2010

Article Tools

* Image Usage & Resolution